HOME >> MEDICINE >> NEWS
Cancer summit launches global commitment to improve cancer care, research and treatment

Chirac, Matsuura and Wiesel Among Signatories of The Charter of Paris Against Cancer

Paris, 4 Feb., 2000 - Today more than 100 international leaders of government, patient advocacy, cancer research organizations and corporations will reaffirm and expand their commitment to the global eradication of cancer by signing The Charter of Paris Against Cancer at the first World Summit Against Cancer. The historic summit, which includes a candlelight ecumenical service on 3 February at the Cathédral of Notre-Dame, culminates with the signing of The Charter at Elysée Palace by Jacques Chirac, president of the Republic of France; Koichiro Matsuura, director general of the United Nations Educational, Scientific and Cultural Organization (UNESCO), Elie Wiesel, Nobel Laureate; HRM Princess Chulabhorn of Thailand and key representatives from the cancer community.

"It has become increasingly apparent that cancer cannot successfully be fought in isolation. The battle can only be won by creating unprecedented global partnerships between government, industry, the scientific community, healthcare providers and those affected by cancer," said David Khayat, M.D., of the Pitié-Salpêtrière Hospital and co-founder of the Summit.

Each year worldwide, nine million new cases of cancer occur and five million people die, reports the World Health Organization (WHO). Due to dramatic increases in life expectancy, changes in lifestyle and tobacco use the number of new cancer cases will rise to 20 million annually by 2020 and cancer deaths will exceed 10 million, despite advances in treatments, reports WHO.

The Charter of Paris Against Cancer is the first global call to action against cancer in the new millennium. Its purpose is to foster improved cancer treatment and research worldwide as well as empower patients by educating them about t
'"/>

Contact: Laurie Miller
Lmiller@porternovelli.com
212-601-8359
Porter Novelli
3-Feb-2000


Page: 1 2

Related medicine news :

1. Cancer in patients with hepatitis C
2. Olson family donates $1 million to Arizona Cancer Center
3. Cancer vaccines: A two-pronged attack?
4. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
5. ESMO and Imedex announce partnership for the World Congress on Gastrointestinal Cancer
6. UT Southwestern Moncrief Cancer Center is first in Texas to treat patients with TomoTherapy
7. Cancer researchers seek to predict tumor growth
8. UGA professor receives $3 million grant from National Cancer Institute for breast cancer research
9. Cancer patients in Europe unite with doctors
10. Fox Chase Cancer Center researchers identify novel target for detecting ovarian cancer in blood
11. Cancer burden seen even many years after diagnosis

Post Your Comments:
(Date:5/20/2013)... NL, 20 May 2013 While Huntington,s disease ... anticipates that new disease-modifying therapies in development may ... of HD research depends upon the identification of ... evaluate therapies, and these biomarkers may eventually be ... could be especially helpful to monitor changes during ...
(Date:5/20/2013)... Horizon NJ Health, New Jersey’s largest ... it has earned a Commendable Accreditation status from ... Health is a wholly owned subsidiary of Horizon Blue ... Health Plan Accreditation is a nationally recognized program that ... plans provide to their members. Health Plan Accreditation performance ...
(Date:5/20/2013)... May 20, 2013 The American Society ... for Bright Pink®, the organization that empowers young women to ... end of 2012. Thanks to its members, ASCP raised more ... is involved in Relay for Life at the local level. ... he decided to donate. “I was made aware of the ...
(Date:5/20/2013)... The nationwide law firm of Bernstein Liebhard LLP ... imaging (MRI) can be used to predict metal-on-metal hip ... experiencing symptoms. According to an article published on May ... MRI detected synovitis (tissue damage) in 68% of asymptomatic patients ... causes, the detection rate was 75%, while MRIs were able ...
(Date:5/20/2013)... MONDAY, May 20 (HealthDay News) -- Boys who are ... likely to become obese adults as those who didn,t ... 30-year study shows. Researchers found that men with ... (BMI) and obesity, even if they no longer had ... well-off or poor, they tended toward obesity. "The ...
Breaking Medicine News(10 mins):Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 3Health News:Horizon NJ Health Awarded Commendable Accreditation by NCQA 2Health News:Horizon NJ Health Awarded Commendable Accreditation by NCQA 3Health News:ASCP Members Rally Around Breast and Ovarian Cancer Awareness 2Health News:ASCP Members Rally Around Breast and Ovarian Cancer Awareness 3Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 2Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 3Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 4Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 2Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 3
(Date:5/20/2013)... YORK , May 20, 2013  Echo Pharma ... 2.5 of the Irish Takeover Rules (the "Announcement"), a ... plc (NYSE: ELN ) to $12.50 per ... cash confirmed and not conditional on due diligence.  The ... Royalty Pharma has reserved the right to waive down ...
(Date:5/20/2013)... , May 20, 2013  Atlantic Pharmaceuticals, Inc., ... is commercializing a unique technology to deter prescription ... President, Anthony Soscia , has ... Atlanta Business Chronicle ,s Health-Care Heroes Awards. The ... Business Chronicle to honor individuals and organizations demonstrating ...
(Date:5/20/2013)... May 20, 2013  Rhythm announced today the presentation ... higher prevalence of gastroparesis symptoms among diabetic patients in ... is high among patients with both type 1 and ... among those with the more common type 2 disease. ... MD, PhD, Associate Professor of Medicine at Harvard Medical ...
Breaking Medicine Technology:Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 4Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 5Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 6Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 7Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 8Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 9Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 10Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 11Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 2Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 3Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 4
Cached News: